ADMA Biologics
Mr. Guiheen has been a director of ADMA since July 2012 and is currently the Chairman of the Company's Governance and Nominations Committee and a member of the Company's Audit Committee. Mr. Guiheen is currently Executive Vice President of Wellstat Management and Chief Executive Officer of Wellmond Therapeutics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices